ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone marrow clues may explain why half of 'good prognosis' leukemia patients relapse
Knowledge-focused CompletedThis study looked at bone marrow cells from 70 adults with a favorable type of acute myeloid leukemia (AML) that has a mutation in the NPM1 gene. Even though these patients are expected to do well with standard treatment, more than half still relapse. Researchers wanted to see if…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC
-
AI steps in to speed up rare blood cancer diagnosis
Knowledge-focused CompletedThis study tested whether artificial intelligence (AI) can help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Ten doctors reviewed bone marrow samples with and without AI assistance. The goal was to see if AI improves …
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC